Recent evidence has encouraged low- and middle-income countries to consider transitioning from long-standing iron and folic acid supplementation (IFAS) to multiple micronutrient supplementation (MMS) for antenatal care programs. However, global guidance to facilitate this transition is limited.
This tool was developed to aid countries’ decision-making. It uses a rigorous methodology to calculate the incremental benefits and costs of transitioning from IFAS to MMS in various countries (Kashi et al., 2018).
Users can construct and test different scenarios by updating the assumptions within the tool or running a Custom Analysis. Up to eight health outcomes are included in the analysis, and aggregated using disability-adjusted life years (DALYs).
- The tool will time out if left idle for more than five minutes. Click the refresh symbol in the web-browser to reset. Please be aware the tool will return to default and you will lose any new data.
- This page must be viewed in Chrome, Firefox, or Edge browsers for the tool to display below and is best viewed on desktop.
Policy Briefs are available for the countries listed on the map. These documents summarize the results of the analysis and are designed for policymakers to answer the question “is antenatal MMS better value for money than IFAS?”